A self-administered anonymous waiting room survey was used to evaluate men's preferences on testing, notification, and treatment for sexually transmitted infections (STIs) in a community clinic in Upper Manhattan in 2007. Sixty-seven percent of eligible men (n = 199) participated. Most were willing to collect a urine sample at home (71%, n = 140) or at the clinic (87%, n = 171). Respondents preferred learning of a positive STI test result by phone (67%, n = 123). However, men were willing to receive results by text (65%, n = 127) or e-mail (61%, n = 121). Most (83%, n = 162) reported they would be (very) likely to take STI medication brought to them by a partner. Twenty-one percent reported previous gonorrhea or Chlamydia infection (n = 41). Of these, 39% (n = 16) had received medication to bring their partner, and almost all (n = 14/16) reported their partner took the medicine. Multiple options for STI testing, notification, and treatment are recommended to maximize service use among men, including providing patient-delivered partner therapy.
Introduction
Although focus on men's sexual and reproductive health has increased since the 1990s, men continue to underutilize sexual and reproductive health services (Sonenstein, 2000) . A variety of professional and nonprofit organizations, such as the American Medical Association (2001), EngenderHealth (2009), and the Urban Institute (Sonenstein, 2000) , have developed strategies for engaging men in sexual and reproductive health services (Sonfield, 2002) . One of the key targets for these strategies is sexually transmitted infection (STI) screening. Reinfection rates of persistent and recurrent Chlamydia infection among women are often the result of resuming sex with untreated sexual partners (Whittington et al., 2001) , indicating a need for increased attention to treatment of STIs among men.
Patient-delivered partner therapy (PDPT), the practice of giving medication or prescriptions to an index case to bring to his/her partner, may be one way to combat reinfection. Of the five randomized controlled studies to evaluate the efficacy of PDPT conducted in the United States (Golden et al., 2005; Cameron et al., 2009; Kissinger et al., 2005; Kissinger et al., 2006; Schillinger et al., 2003) , only one exclusively studied giving PDPT to men as the index case and reported that it reduced reinfections compared with standard partner referral (Kissinger et al., 2005) . PDPT is legal in 15 states, potentially legal in 24 additional states, and prohibited in 11 states (Centers for Disease Control and Prevention, 2009); PDPT for Chlamydia infection was explicitly made legal in New York State in 2008.
Based on the need for improved STI screening in men, an anonymous cross-sectional survey was provided to men in the waiting room of a clinic to examine their preferences for STI testing, notification, and treatment, including willingness to use PDPT in a clinic where PDPT is offered. Furthermore, differences in preferences by STI history, age, and by self-reported sexual relations with men are described.
Materials and Method Study Setting
Men in the waiting room of the Young Men's Clinic (YMC), a community-based clinic in the Washington Heights neighborhood of New York City, were recruited. YMC, which is operated by the Center for Community Health and Education at Columbia University's Mailman School of Public Health and New York-Presbyterian Hospital, has been serving young men since 1987 (Armstrong, 1999 (Armstrong, , 2003 
Study Design, Sampling, and Data Collection
A cross-sectional, anonymous survey was conducted over a 4-week period in summer 2007 with the goal of enrolling at least 200 men; this sample size would allow assessment of preferences for an estimated 10% of men who would report ever having had an STI with standard errors of 2% to 4%. Men 18 years or older were recruited from the YMC waiting room using convenience sampling. Men who were attending the clinic themselves or accompanying a friend or partner were approached and asked to complete a selfadministered survey. An immediate review of each survey was used to ensure completeness. Participants received a $4 Metrocard for New York City public transportation. The institutional review board at Columbia University Medical Center approved the study; men received written informed consent information and, to maintain anonymity, provided verbal consent.
Dual-language (English and Spanish) questionnaires focused on five domains: sociodemographic characteristics, sexual and health history, experiences with and preferences for collecting specimens to be tested for STIs, preferences for notification of STI test results, and experiences and preferences for partner notification and treatment given a positive test. The questionnaire was reviewed by clinicians and health educators at the clinic for overall comprehension level and use of medical terminology. Additionally, the questionnaire was pretested with 21 men from the waiting room with both English and Spanish speakers represented. Pretesting was used to probe understanding of the questions using qualitative techniques and to identify questions respondents had difficulties interpreting. Adjustments were made to the questionnaire based on the results of the pretesting.
The main study outcomes were preferences for testing, result notification, and partner notification and treatment. The questionnaire first solicited which approaches men would be willing to try for specimen collection, notification of results, and partner notification and treatment, and concluded with questions about their first choice preferences.
Men were asked about testing approaches for urethral and anal infections; results for anal infection preferences are reported for men who have sex with men (MSM) only. The questionnaire asked specifically about PDPT using a series of 4-point Likert-type scale questions and about potential barriers to bringing medication to a partner. Men were asked how likely they would be to bring medicine to their partner, how likely it was that their partner would take medication brought to them, and how likely the men themselves would be to take medication brought to them by their partner.
Data Analysis
Men's preferences for STI testing, notification, and treatment are described. Group differences in preferences were explored by risk groups including by self-reported STI history, by age (less than 25 vs. 25 and older, based on median age), and by self-reported sexual relations with men. Fisher's exact tests were used for dichotomous variables and Mann-Whitney tests for continuous variables in these bivariate analyses of STI service preferences. Group differences by ever reporting an STI and age are presented in the tables; differences by MSM status are described in the text. All analyses were conducted using the Statistical Package for the Social Sciences (SPSS, Inc., 2006) .
Results

Demographics and Sexual History
Of the 295 men approached, 199 completed the surveys (67%). The main reason for declining participation was being occupied with another activity (i.e., reading magazine, watching movie, talking to friend). Respondents were primarily Latino (84%, n = 165), high school graduates or higher (76%, n = 149), and fairly young (median age = 25 years, range = 18-53 years, Table 1 ). Twenty-one percent overall reported ever being diagnosed with gonorrhea and/or Chlamydia infection (n = 41). Thirteen percent reported sexual relations with other men (n = 25) and were more likely to report having ever tested positive for gonorrhea and/or Chlamydia infection (23%, n = 9, vs. 11%, n = 16, p = .06). When asked whether they used a condom at last anal sex, 38% (n = 74) reported they had never had anal sex; of those who reported having anal sex, 61% (n = 73) reported they had not used a condom at last anal sex; and 39% (n = 46) reported they had used a condom at last anal sex. Men were asked about condom use during anal sex directly without first being asked whether they engaged in anal sex. Of those who reported on condom usage at last anal sex, 77% (n = 90) reported that their last sexual partner was female.
STI Testing
Most respondents were willing to collect a urine sample at home (71%, n = 140) or at the clinic (87%, n = 171, Table 2 ). The first choice preference, however, for the majority was to take a urine specimen at the clinic (52%, n = 101). No differences in preferences were seen by STI history. Younger men (≤24 years) indicated less willingness to collect a urine sample at home (60%, n = 59) compared with older men (82%, n = 81, p = .001).
Anoreceptive sex among MSM can lead to asymptomatic anal STI infection, which can be missed in routine screening efforts (Manavi, McMillan, & Young, 2004) . To assess anal infections, the majority of MSM (72%, n = 18) were willing to take their own anal swab. In fact, the first choice preference for screening anal infections among MSM was selfcollection (44%, n = 11), with fewer preferring doctor collection (20%, n = 5), and about one third (36%, n = 9) reporting no preference either way.
STI Results Notification
In terms of receiving the results of STI tests, most men were willing to have the clinic contact them by telephone (86%, n = 170) or to contact the clinic themselves (82%, Table 2 ). Nearly two thirds were willing to receive results by a mailed letter (65%, n = 127), text message (65%, n = 127), or e-mail (61%, n = 121). No differences were seen by ever having had gonorrhea and/or Chlamydia infection or by MSM status; however, these preferences differed by age. Fewer young men (≤24 years) were willing to receive a mailed letter (55%, n = 53) than their older counterparts (75%, n = 74, p = .005). Similarly, young men were less willing to contact the clinic themselves (77%, n = 75, vs. 87%, n = 86, p = .10) and were more likely to indicate the phone was their first choice method of notification (74%, n = 67, vs. 61%, n = 55, p = .08).
Partner Notification and Treatment
For partner treatment, most men were willing to bring their sexual partner to the clinic (93%, n = 183) or bring extra medication (82%, n = 162), a prescription (77%, n = 152), or a list of clinics (79%, n = 155) to their partner (Table 3) . Men who self-reported having ever been diagnosed with gonorrhea and/or Chlamydia infection were more likely to indicate that they would be willing to take medication to their partner compared with those who reported never having had an infection (93%, n = 38, vs. 80%, n = 124, p = .06). The majority of respondents indicated that they would be likely to bring medicine to their partner (72%, n = 141, very likely, and 12%, n = 23, somewhat likely) if given PDPT. This result differed by STI history; 85% (n = 34) of men who had had an infection reported they would be very likely to bring medication to their partner compared with 69% (n = 107) of those who had never had an infection (p = .048). Most respondents indicated their partner would take medication brought to them (63%, n = 122, very likely, and 20%, n = 38, somewhat likely) with more men who ever had an STI choosing very likely (78%, n = 31, vs. 59%, n = 91, p = .03). Finally, the majority of participants indicated they would likely take STI medication brought to them by a partner. (67%, n = 131, very likely, and 16%, n = 31, somewhat likely). Men who previously had an STI more frequently reported they would very likely take medication brought to them by a partner than those who had never had an STI (88%, n = 35, vs. 62%, n = 96, p = .001). Partner notification and treatment outcomes did not differ by age or MSM status. Although men were willing to bring PDPT to their partners and likely to take medication brought to them by a partner, the majority (76%, n = 147) of men's first choice was to bring their partner to the clinic for treatment. Only 6% (n = 11) listed PDPT (prescription or medication) as their first choice. The YMC has been providing PDPT for Chlamydia infection at the physicians' discretion since 2006. Respondents previously diagnosed with an STI were therefore asked about their experiences with PDPT. Of the 21% (n = 41) who reported having ever had gonorrhea and/or Chlamydia infection, 39% (n = 16) were given medication to bring their partner and almost all (88%, n = 14) reported their partner took the medicine. Among all surveyed, regardless of STI history, barriers to PDPT most commonly endorsed were that they felt only a doctor or nurse should give medicine (39%, n = 77), or they would want their partner to go to the clinic themselves (35%, n = 69). Barriers to PDPT differed by ever having an STI and MSM status. A higher percentage of respondents who had ever had an STI wanted their partner to go to the clinic themselves (49%, n = 20, vs. 32%, n = 49, p = .04). Similarly, a higher percentage of MSM wanted their partner to go to the clinic themselves compared with non-MSM (60%, n = 15, vs. 33%, n = 52, p = .01). Additionally, a higher percentage of MSM indicated that fear of a partner leaving them was a barrier to PDPT (20%, n = 5, vs. 8%, n = 12, p = .06).
Discussion
Men in our study were open to many different methods of STI testing. The majority were willing to take a urine sample at home and either mail the sample or bring it to the clinic. Many European countries use home-based sampling for STI screening Novak & Karlsson, 2006; Veldhuijzen et al., 2005) . The results presented here indicate that at-risk men are willing to use home-based urine sampling, which should be further explored to increase screening coverage. A study assessing acceptability of home screening of Chlamydia infection by urine sample among men and women in the United Kingdom found that men were as likely as women to participate (Stephenson et al., 2000) . The results from the present study further indicate that home-based sampling may be a useful way to screen the male partners of men or women who test positive for STIs and/or a desirable way to test for reinfection among men who have difficulty returning to the clinic for follow-up visits.
Although anal human papillomavirus infection among MSM has been well documented (Dunne, Nielson, Stone, Markowitz, & Giuliano, 2006) , less is known about rectal Chlamydia and gonorrhea infection (Kent et al., 2003; Manavi et al., 2004) . MSM engaging in receptive anal sex are vulnerable to anal STI infection and consistent condom use may have limited effect on STI transmission in this population (Whittington et al., 2002) . Therefore, it is crucial for practitioners to be aware of this risk among MSM patients and screen appropriately. Anal STI infection education may increase men's willingness to be tested for anal infections. Offering MSM the choice between self-collection and clinician collection of anal swabs may maximize uptake of these screening services.
Telephone notification of test results was the first choice of most men in our study, which is consistent with other studies on receiving sexual health screening results (Brown, Copas, Stephenson, Gilleran, & Ross, 2008) . Men's acceptance of alternative test result notification methods, such as e-mail and text messaging, is promising. As technological advances increase security of e-mail and text messaging, result notification by these methods should be explored, as they require less clinic staff time and may increase efficiency. Differences in notification preferences were found by age, underlining the importance of considering confidentiality concerns for younger patients.
Most men's first preference was to notify a partner themselves and ask their partner to attend a clinic for treatment and counseling; clinicians should continue to offer these options. However, men were also willing to explore alternative partner notification and treatment strategies, suggesting that providing men with choices may ultimately increase partner treatment coverage. Although men's first choice was to have their partner go to the clinic in person, this may not always be feasible. When the ideal situation of having a partner seen by a clinician is not possible, PDPT seems to be an acceptable alternative.
Results from a randomized controlled trial in 2005, in which men were offered PDPT, indicated that men given PDPT were less likely to have a recurrent STI than partner referral participants and more likely to report that their partners took antibiotics (Kissinger et al., 2005) . Our results suggest many men (both heterosexual and MSM) in a community-based clinic setting would agree to PDPT and believe their partner would be willing to take the medication. Furthermore, our results show that when a man brings medication to his partner she/he would likely take it: the vast majority of men who had actually received PDPT treatment for a past STI indicated that they delivered the medication to their partner and that their partner took the medication. Thus, PDPT appears to be a viable strategy for treating STIs in this population.
This study has some limitations. The sample was primarily Latino; findings may not generalize to men of other ethnicities. Some selection bias may be present; one third of eligible men chose not to participate and their preferences may be different from those who participated. Additionally, men aged 18 years or younger were excluded due to ethical concerns for their participation per the institutional review board; preferences for this group are important to understand given their elevated risk for STIs. Some men may have had difficulty understanding technical terms in the study questionnaire as indicated by the finding that 8% of respondents preferred STI testing by urethral swab. Clinic staff felt that 13% reporting of MSM behavior was high for their clinic population, suggesting the possibility that MSM were more likely to participate in the study. This study relies on self-reported sexual behavior and history, which are subject to error (Fenton, Johnson, McManus, & Erens, 2001) ; however, the survey was selfadministered and anonymous to minimize underreporting. Furthermore, self-reports on ever having had gonorrhea and/or Chlamydia infection were reasonable and consistent with overall clinic numbers; 15% (n = 29) of the respondents reported ever having Chlamydia infection and 6% (n = 12) ever having gonorrhea, which is plausible given 10% positivity of Chlamydia tests from 2006 clinic data (135 out of 1,348 tests) and less than 1% positivity of gonorrhea (10 out of 1,348 tests).
Given that STIs persist, improvement of STI management for secondary prevention is needed. Clinical settings should explore offering men options for STI management to increase coverage and acceptability of services. Two clear services that should be incorporated are offering selfcollection and clinician collection of anal swabs for anal infection screening among MSM and offering PDPT to men, including MSM, who indicate their partner is not likely to come to the clinic for treatment.
